// App-Quantinova.ai

: Baseline characteristics and comorbid conditions in patients with moderate-to-severe plaque psoriasis enrolled in the Psoriasis Study of Health Outcomes (PSoHO)

Researchers

Presenter

  • Lluís Puig

Principal Investigators

  • Adam Reich

  • Shirin Zaheri

  • Charles Lynde

  • Alan Brnabic

  • Julie Hill

  • Catherine Reed

  • Christopher Schuster

  • Elisabeth Riedl

  • Knut Schäkel

Medical Centers

  • Pharmacy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain,

  • Department of Dermatology, University of Rzeszow, Rzeszow, POLAND

  • Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, UK

  • Lynde Institute for Dermatology, Markham, Canada

  • Eli Lilly and Company, Indianapolis, IN

  • Department of Urology, Medical University Vienna, Vienna, Austria

  • Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany

Locations

  • United Kingdom

  • South Africa

  • Spain

  • Poland

  • Canada

  • United States

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Dermatology

Disease

  • Psoriatic arthritis

  • Psoriasis

  • Dyslipidemia

  • Hypertension

  • Inflammatory Arthritis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • Non Interventional

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved